295 related articles for article (PubMed ID: 6508330)
41. Skin directed therapy for mycosis fungoides: a review.
Berthelot C; Rivera A; Duvic M
J Drugs Dermatol; 2008 Jul; 7(7):655-66. PubMed ID: 18664158
[TBL] [Abstract][Full Text] [Related]
42. Ointment-based mechlorethamine treatment for mycosis fungoides.
Price NM; Hoppe RT; Deneau DG
Cancer; 1983 Dec; 52(12):2214-9. PubMed ID: 6640491
[TBL] [Abstract][Full Text] [Related]
43. Narrowband UVB and PUVA in the treatment of mycosis fungoides: a retrospective study.
Ahmad K; Rogers S; McNicholas PD; Collins P
Acta Derm Venereol; 2007; 87(5):413-7. PubMed ID: 17721648
[TBL] [Abstract][Full Text] [Related]
44. 13-cis-retinoic acid effective in mycosis fungoides. A report from the Scandinavian Mycosis Fungoides Group.
Thomsen K; Molin L; Volden G; Lange Wantzin G; Hellbe L
Acta Derm Venereol; 1984; 64(6):563-6. PubMed ID: 6084938
[TBL] [Abstract][Full Text] [Related]
45. Scandinavian mycosis fungoides trial.
Thomsen K
Cancer Treat Rep; 1979 Apr; 63(4):709-11. PubMed ID: 445520
[No Abstract] [Full Text] [Related]
46. Mycosis fungoides in a lung transplant recipient with advanced ciclosporin nephropathy: management with mechlorethamine and subsequent renal transplantation.
Laffitte E; Venetz JP; Aubert JD; Duchosal MA; Panizzon RG; Pascual M
Dermatology; 2008; 217(1):87-8. PubMed ID: 18446031
[TBL] [Abstract][Full Text] [Related]
47. Does adjuvant alpha-interferon improve outcome when combined with total skin irradiation for mycosis fungoides?
Roberge D; Muanza T; Blake G; Shustik C; Vuong T; Freeman CR
Br J Dermatol; 2007 Jan; 156(1):57-61. PubMed ID: 17199567
[TBL] [Abstract][Full Text] [Related]
48. Phase 1/2 pilot study of methotrexate-laurocapram topical gel for the treatment of patients with early-stage mycosis fungoides.
Demierre MF; Vachon L; Ho V; Sutton L; Cato A; Leyland-Jones B
Arch Dermatol; 2003 May; 139(5):624-8. PubMed ID: 12756099
[TBL] [Abstract][Full Text] [Related]
49. Small malignant melanoma in patients with mycosis fungoides.
Amichai B; Grunwald MH; Goldstein J; Finkelstein E; Halevy S
J Eur Acad Dermatol Venereol; 1998 Sep; 11(2):155-7. PubMed ID: 9784043
[TBL] [Abstract][Full Text] [Related]
50. Tazarotene 0.1% gel for refractory mycosis fungoides lesions: an open-label pilot study.
Apisarnthanarax N; Talpur R; Ward S; Ni X; Kim HW; Duvic M
J Am Acad Dermatol; 2004 Apr; 50(4):600-7. PubMed ID: 15034511
[TBL] [Abstract][Full Text] [Related]
51. [Perforating follicular mucinosis and immediate hypersensitivity to mechlorethamine in a patient with mycosis fungoides].
Guilhou JJ; Barnéon G; Malbos S; Peyron JL; Michel B; Meynadier J
Ann Dermatol Venereol; 1980; 107(1-2):59-62. PubMed ID: 7369659
[No Abstract] [Full Text] [Related]
52. Granulomatous mycosis fungoides. A 14-year follow-up of a case.
Flaxman BA; Koumans JA; Ackerman AB
Am J Dermatopathol; 1983 Apr; 5(2):145-51. PubMed ID: 6881480
[TBL] [Abstract][Full Text] [Related]
53. Commentary and update: topical chemotherapy with mechlorethamine for mycosis fungoides.
Vonderheid EC; Van Scott EJ
Cleve Clin Q; 1983; 50(2):97-100. PubMed ID: 6640944
[No Abstract] [Full Text] [Related]
54. Topical 5-aminolevulinic acid photodynamic therapy for the treatment of unilesional mycosis fungoides: a report of two cases and review of the literature.
Recio ED; Zambrano B; Alonso ML; de Eusebio E; Martín M; Cuevas J; Jaén P
Int J Dermatol; 2008 Apr; 47(4):410-3. PubMed ID: 18377612
[TBL] [Abstract][Full Text] [Related]
55. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
[TBL] [Abstract][Full Text] [Related]
56. Urticaria and anaphylactoid reactions after topical application of mechlorethamine.
Daughters D; Zackheim H; Maibach H
Arch Dermatol; 1973 Mar; 107(3):429-30. PubMed ID: 4692132
[No Abstract] [Full Text] [Related]
57. Complete regressions of mycosis fungoides with topical mechlorethamine hydrochloride.
Van Scott EJ
JAMA; 1972 Nov; 222(9):1172. PubMed ID: 4678061
[No Abstract] [Full Text] [Related]
58. [Contact urticaria and anaphylactic reactions induced by topical application of nitrogen mustard].
Sánchez Yus E; Surárez Martín E
Actas Dermosifiliogr; 1977; 68(12):39-44. PubMed ID: 140594
[No Abstract] [Full Text] [Related]
59. Narrowband UVB phototherapy for early-stage mycosis fungoides: evaluation of clinical and histopathological changes.
Gökdemir G; Barutcuoglu B; Sakiz D; Köşlü A
J Eur Acad Dermatol Venereol; 2006 Aug; 20(7):804-9. PubMed ID: 16898902
[TBL] [Abstract][Full Text] [Related]
60. A phase II open-label study of recombinant human interleukin-12 in patients with stage IA, IB, or IIA mycosis fungoides.
Duvic M; Sherman ML; Wood GS; Kuzel TM; Olsen E; Foss F; Laliberté RJ; Ryan JL; Zonno K; Rook AH
J Am Acad Dermatol; 2006 Nov; 55(5):807-13. PubMed ID: 17052486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
